Refresh

Biocon Ltd.

Price on BSE   21 Jan,15:29 LIVE
365.00
-1.55
(-0.42%)

© 2026 Rediff.com
  • Volume :
  • 123,654.00
  • Prev Close :
  • 366.55
  • Day's H/L (Rs.) :
  • 370.00 - 359.05
  • 52wk H/L (Rs.) :
  • 424.95 - 290.80
  • Mkt Cap (Rs. Cr) :
  • 59,162.85
Price on NSE   21 Jan,15:59 LIVE
364.85
-2.00
(-0.55%)

© 2026 Rediff.com
  • Volume :
  • 2,608,596.00
  • Prev Close :
  • 366.85
  • Day's H/L (Rs.) :
  • 370.05 - 359.05
  • 52wk H/L (Rs.) :
  • 424.95 - 291.00
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Biocon launches diabetes & obesity drugs in Netherlands
Rediff.com   16 Dec 2025
'We're 2 biggest fugitives': Lalit Modi, Mallya mock India
Rediff.com   24 Dec 2025
USFDA's new draft biosimilar rules to benefit Indian biotech cos
Rediff.com   09 Nov 2025
Report Card - Biocon Ltd.
PE Ratios
72.12
EPS (Rs.)
5.07
Sales (Rs. Cr)
583.30
Face Value (Rs.)
5
Net Profit Margin(%)
27.16
Last Bonus
1:1
Last Dividend(%)
10
Return on Average Equity
5.28

News for Biocon Ltd.

Syngene & Bristol Myers Squibb Extend Collaboration
Syngene International extends research collaboration with Bristol Myers Squibb through 2035, expanding drug development services.
Jan 19, 2026 18:18
Biocon Raises Rs 4,150 Cr via QIP Issue
Biocon raises Rs 4,150 crore through QIP. Funds to buy Mylan (Viatris) stake in Biocon Biologics. Focus on biosimilars, diabetes, oncology.
Jan 15, 2026 11:24
Biocon Gets USFDA Nod for Generic Everolimus Tablets
Biocon Pharma receives USFDA approval for generic Everolimus tablets, used to treat tuberous sclerosis complex (TSC).
Jan 12, 2026 13:43
Biocon Biologics: New Biosimilars for Cancer Treatment
Biocon Biologics to launch Trastuzumab, Nivolumab, Pembrolizumab biosimilars for cancer. Expanding oncology portfolio. Details here.
Jan 06, 2026 19:06
Biocon Licenses Diabetes Drug to Ajanta Pharma
Biocon out-licenses its diabetes drug Semaglutide to Ajanta Pharma for export to 23 countries in Africa, Middle East & Central Asia.
Dec 23, 2025 19:23

More News for Biocon Ltd. »

News for Pharmaceuticals and health care

Invest in Bengaluru: D K Shivakumar at WEF Davos
D K Shivakumar invites global investors to Bengaluru at WEF Davos. Highlights Bengaluru's strengths in IT, talent, and infrastructure.
Jan 21, 2026 18:11
Canara HSBC Life Q3 Profit Drops 6% to Rs 28 Cr
Canara HSBC Life Insurance reports a 6% drop in Q3 net profit to Rs 27.65 crore. Total income rises to Rs 4,272.53 crore.
Jan 21, 2026 17:57
Bharat Electricity Summit 2026 Roadshow in Kolkata
Roadshow for Bharat Electricity Summit 2026 held in Kolkata. Discussing India's electricity landscape and event objectives.
Jan 21, 2026 17:55
Bullion Rates Today: Gold & Silver Prices
Latest closing bullion rates in Bengaluru. Check today's gold prices (22K & 24K) and silver rates per KG. Stay updated on market trends.
Jan 21, 2026 17:42
Eternal Q3 Profit Up; Deepinder Goyal Steps Down
Eternal reports 73% profit rise in Q3. Deepinder Goyal resigns as CEO, Albinder Singh Dhindsa appointed. Read the latest updates.
Jan 21, 2026 16:45

More News »

Top News

Dr Reddy''s Q3 Profit Dips 14% to Rs 1,210 Cr
Dr Reddy''s Q3FY26 profit declines 14% to Rs 1,210 crore due to lower US sales. Revenue rises to Rs 8,727 crore. India sales up 19%.
Jan 21, 2026 18:20
India at Davos: Economic Growth & Sustainability
Indian leaders at Davos highlight economic growth, sustainability, renewable energy targets, and investment opportunities in India.
Jan 21, 2026 18:18
Invest in Bengaluru: D K Shivakumar at WEF Davos
D K Shivakumar invites global investors to Bengaluru at WEF Davos. Highlights Bengaluru's strengths in IT, talent, and infrastructure.
Jan 21, 2026 18:11
RBI Bulletin: Optimism for Indian Economy
RBI bulletin expresses optimism about the Indian economy, projecting it as the fastest-growing major economy despite global risks.
Jan 21, 2026 18:08
MakeMyTrip Q3 Profit Up 14.47% to USD 51.4 Million
MakeMyTrip Ltd reports a 14.47% rise in adjusted net profit to USD 51.4 million in Q3. Revenue grew 15.4% to USD 295.7 million.
Jan 21, 2026 17:59

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com